Menu

• Ask a Health Expert about METASTASES TO ABDOMINAL CAVITY
• Post Your Side Effect related to METASTASES TO ABDOMINAL CAVITY
• METASTASES TO ABDOMINAL CAVITY and FDA Warnings
• METASTASES TO ABDOMINAL CAVITY in Patients Wiki
• Report METASTASES TO ABDOMINAL CAVITY in Drug Side Effect Survey

METASTASES TO ABDOMINAL CAVITY side effect

What is METASTASES TO ABDOMINAL CAVITY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Quadramet Side Effects Report #5352524-0
Health Professional from UNITED STATES reported QUADRAMET problem on Dec 06, 2006. Male patient, 78 years of age, was diagnosed with metastases to bone and was treated with QUADRAMET. After drug was administered, patient experienced the following problems/side effects: metastases to abdominal cavity, pain, thrombocytopenia, . QUADRAMET dosage: unknown. During the same period patient was treated with TECHNETIUM TC. Patient died.

Actonel Side Effects Report #5491338-8
ACTONEL problem was reported by a Physician from CANADA on Oct 05, 2007. Female patient, 81 years of age, weighting 95.02 lb, was diagnosed with osteoporosis and was treated with ACTONEL. After drug was administered, patient experienced the following problems/side effects: hypertension, metastases to abdominal cavity, ovarian cancer metastatic, . ACTONEL dosage: 35 MG, 1/WEEK, ORAL. During the same period patient was treated with SYNTHROID, MIACALCIN, PANTOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Infliximab Side Effects Report #5591191-8
Physician from UNITED STATES reported INFLIXIMAB problem on Jan 09, 2008. Male patient, weighting 161.0 lb, was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, colon cancer, metastases to abdominal cavity, signet-ring cell carcinoma, . INFLIXIMAB dosage: unknown. Patient was hospitalized. Patient died on 10/08/2007.

Prograf Side Effects Report #5419995-2
PROGRAF problem was reported by a Physician from JAPAN on Aug 02, 2007. Female patient, 41 years of age, was diagnosed with myasthenia gravis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, malignant neoplasm progression, metastases to abdominal cavity, metastasis, respiratory failure, thymoma malignant recurrent, . PROGRAF dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with MYTELASE, PREDNISOLONE, ATROPINE SULPHATE, GASTERLET, SELBEX, BIOFERMIN. Patient died on 12/29/2005.


Cenestin Side Effects Report #5379575-4
Consumer or non-health professional from JAPAN reported CENESTIN problem on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with CENESTIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes, . CENESTIN dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE. Patient died.

Cenestin Side Effects Report #5379575-4
CENESTIN problem was reported by a Consumer or non-health professional from JAPAN on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with CENESTIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes, . CENESTIN dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE. Patient died.

Remicade Side Effects Report #5749243-5
Physician from UNITED STATES reported REMICADE problem on May 16, 2008. Male patient, weighting 161.0 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, colon cancer, metastases to abdominal cavity, . REMICADE dosage: unknown. Patient was hospitalized. Patient died on 10/08/2007.

Cisplatin Side Effects Report #5289280-0
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Male patient, weighting 137.8 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: lung consolidation, lung infiltration, metastases to abdominal cavity, metastases to central nervous system, neutropenia, pneumonia, . CISPLATIN dosage: 140 MG. During the same period patient was treated with ETOPOSIDE. Patient recovered.